IL105119A - אימונוגלובינים ואנטיגנים לטיפול בזיהומים סטאפילוקוקיים, שיטות לזיהויים ולהכנתם ותכשירי רוקחות המכילים אותם - Google Patents

אימונוגלובינים ואנטיגנים לטיפול בזיהומים סטאפילוקוקיים, שיטות לזיהויים ולהכנתם ותכשירי רוקחות המכילים אותם

Info

Publication number
IL105119A
IL105119A IL10511993A IL10511993A IL105119A IL 105119 A IL105119 A IL 105119A IL 10511993 A IL10511993 A IL 10511993A IL 10511993 A IL10511993 A IL 10511993A IL 105119 A IL105119 A IL 105119A
Authority
IL
Israel
Prior art keywords
epidermidis
immunoglobulin
staphylococcus
preparation
antigen
Prior art date
Application number
IL10511993A
Other languages
English (en)
Other versions
IL105119A0 (en
Original Assignee
Jackson H M Found Military Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26709752&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL105119(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jackson H M Found Military Med filed Critical Jackson H M Found Military Med
Publication of IL105119A0 publication Critical patent/IL105119A0/xx
Publication of IL105119A publication Critical patent/IL105119A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL10511993A 1992-03-19 1993-03-19 אימונוגלובינים ואנטיגנים לטיפול בזיהומים סטאפילוקוקיים, שיטות לזיהויים ולהכנתם ותכשירי רוקחות המכילים אותם IL105119A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85402792A 1992-03-19 1992-03-19
US3347693A 1993-03-18 1993-03-18

Publications (2)

Publication Number Publication Date
IL105119A0 IL105119A0 (en) 1993-08-18
IL105119A true IL105119A (he) 1999-06-20

Family

ID=26709752

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10511993A IL105119A (he) 1992-03-19 1993-03-19 אימונוגלובינים ואנטיגנים לטיפול בזיהומים סטאפילוקוקיים, שיטות לזיהויים ולהכנתם ותכשירי רוקחות המכילים אותם

Country Status (12)

Country Link
EP (3) EP1027896A1 (he)
JP (3) JP4124816B2 (he)
AT (1) ATE197506T1 (he)
AU (1) AU3805893A (he)
CA (1) CA2132421C (he)
DE (1) DE69329642T3 (he)
DK (1) DK0635132T4 (he)
ES (1) ES2155450T5 (he)
GR (1) GR3035155T3 (he)
IL (1) IL105119A (he)
PT (1) PT635132E (he)
WO (1) WO1993019373A1 (he)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US7279162B1 (en) 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US6632432B1 (en) 1990-10-22 2003-10-14 Henry M. Jackson Foundation For The Advancement Of Military Medicine Directed human immune globulin for the prevention and treatment of staphylococcal infections
ATE209659T1 (de) * 1994-09-21 2001-12-15 Jackson H M Found Military Med Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren
AU2006203322B2 (en) * 1997-06-16 2010-04-29 Altor Bioscience Corporation Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
AU5867100A (en) * 1999-05-03 2000-12-12 Medarex, Inc. Human antibodies to staphylococcus aureus
WO2004043405A2 (en) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
EP1583517B1 (en) 2002-11-12 2019-06-12 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
ES2738112T3 (es) 2004-04-21 2020-01-20 Brigham & Womens Hospital Inc Péptidos de fijación a la poli-N-acetil glucosamina (PNAG/dPNAG) y procedimientos para el uso de los mismos
BRPI0516974A (pt) 2004-10-21 2008-09-30 Wyeth Corp composição imunogênica compreendendo um polipeptìdeo; um método para induzir uma resposta imune contra staphylococcus epidermidis; um método para induzir uma resposta imune contra staphylococcus aureus; um método para a detecção e/ou identificação de staphylococcus epidermidis; um método para a detecção e/ou identificação de anticorpos para staphylococcus epidermidis
US7807415B2 (en) 2005-08-23 2010-10-05 Iq Therapeutics Bv Methods of producing stable B-lymphocytes
EP1821053B1 (en) 2006-01-31 2015-11-04 Electrolux Home Products Corporation N.V. Rapid chilling apparatus for beverages and method for controlling the same
WO2010011284A2 (en) 2008-07-21 2010-01-28 The Brigham And Women's Hospital, Inc. Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
BRPI1015567A2 (pt) 2009-06-22 2021-08-31 Wyeth Llc Composições imunogênicas de antígenos de staphylococcus aureus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
AU591017B2 (en) * 1986-12-15 1989-11-23 Mitsui Toatsu Chemicals Inc. Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
WO1993017044A1 (en) * 1992-02-25 1993-09-02 U.S. Government, As Represented By The Secretary Of The Army Directed human immune globulin for the prevention and treatment of staphylococcal infections

Also Published As

Publication number Publication date
AU3805893A (en) 1993-10-21
JP2007119468A (ja) 2007-05-17
JPH07507387A (ja) 1995-08-10
JP2002255998A (ja) 2002-09-11
DE69329642D1 (de) 2000-12-14
DE69329642T2 (de) 2001-03-15
ATE197506T1 (de) 2000-11-11
EP0635132B1 (en) 2000-11-08
EP1027896A1 (en) 2000-08-16
EP0635132B2 (en) 2008-05-14
ES2155450T3 (es) 2001-05-16
CA2132421C (en) 2010-11-23
DK0635132T3 (da) 2001-02-26
JP4124816B2 (ja) 2008-07-23
JP4171596B2 (ja) 2008-10-22
EP0635132A1 (en) 1995-01-25
DE69329642T3 (de) 2009-05-20
ES2155450T5 (es) 2008-11-01
CA2132421A1 (en) 1993-09-20
PT635132E (pt) 2001-03-30
DK0635132T4 (da) 2008-08-25
EP1033135A1 (en) 2000-09-06
IL105119A0 (en) 1993-08-18
WO1993019373A1 (en) 1993-09-30
GR3035155T3 (en) 2001-04-30
JP4353974B2 (ja) 2009-10-28

Similar Documents

Publication Publication Date Title
US5571511A (en) Broadly reactive opsonic antibodies that react with common staphylococcal antigens
JP4353974B2 (ja) 通常のスタフィロコーカス抗原と反応する広い反応性のオプソニン抗体
US20080139789A1 (en) Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection
US6692739B1 (en) Staphylococcal immunotherapeutics via donor selection and donor stimulation
AU762978B2 (en) Staphylococcal immunotherapeutics via donor selection and donor stimulation
CN102089005A (zh) 金黄色葡萄球菌特异性抗体制剂
US6632432B1 (en) Directed human immune globulin for the prevention and treatment of staphylococcal infections
US7279162B1 (en) Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
JP2010142230A (ja) グラム陽性菌由来の表面固定化タンパク質を同定するためのバイオインフォマティクス法及びそれによって得られるタンパク質
AU673508B2 (en) Directed human immune globulin for the prevention and treatment of staphylococcal infections
CA2200691C (en) Broadly reactive opsonic antibodies reactive with common staphylococcal antigens
WO1996009321A9 (en) Broadly reactive opsonic antibodies reactive with common staphylococcal antigens
Alcántar-Curiel et al. Klebsiella pneumoniae 35 and 36 kDa porins are common antigens in different serotypes and induce opsonizing antibodies
CN113648409A (zh) L-鼠李糖抗体在制备预防和/或治疗耐药细菌感染的药物中的应用
JPS62502284A (ja) 抗原的に活性な蛋白質及び淋病の診断におけるその使用

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired